Evaxion Biotech Incorporates Filings into Registration Statements
Ticker: EVAX · Form: 6-K · Filed: Mar 26, 2025 · CIK: 1828253
| Field | Detail |
|---|---|
| Company | Evaxion Biotech A/S (EVAX) |
| Form Type | 6-K |
| Filed Date | Mar 26, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: filing-incorporation, registration-statement, administrative
Related Tickers: EVX
TL;DR
EVX is rolling over old filings into new ones, standard procedure for ongoing stock activity.
AI Summary
Evaxion Biotech A/S filed a Form 6-K on March 26, 2025, to incorporate by reference its previous filings into various registration statements. These include S-8 (File No. 333-255064), F-3 (File No. 333-265132), and multiple F-1 and F-3 filings, indicating ongoing capital raising or securities offerings.
Why It Matters
This filing is procedural, indicating the company is maintaining active registration statements, which is often a prerequisite for future stock offerings or employee stock plans.
Risk Assessment
Risk Level: low — This is a routine administrative filing and does not introduce new financial or operational risks.
Key Players & Entities
- Evaxion Biotech A/S (company) — Registrant
- 333-255064 (registration_statement) — Form S-8 File Number
- 333-265132 (registration_statement) — Form F-3 File Number
- 333-266050 (registration_statement) — Form F-1 File Number
- 333-276505 (registration_statement) — Form F-1 File Number
- 333-279153 (registration_statement) — Form F-1 File Number
- 333-283304 (registration_statement) — Form F-1 File Number
- 333-285778 (registration_statement) — Form F-3 File Number
FAQ
What is the purpose of this Form 6-K filing for Evaxion Biotech A/S?
The purpose is to incorporate by reference previous filings into several of the Company's registration statements, including Form S-8 and various Form F-1 and F-3 filings.
What is the filing date of this Form 6-K?
The filing date is March 26, 2025.
Which registration statements are being updated by this filing?
The filing is incorporated by reference into registration statements on Form S-8 (File No. 333-255064), Form F-3 (File No. 333-265132), and multiple Form F-1 and Form F-3 filings.
What is the principal executive office address of Evaxion Biotech A/S?
The address is Dr. Neergaards Vej 5f, DK-2970 Hoersholm, Denmark.
Does Evaxion Biotech A/S file annual reports under Form 20-F or 40-F?
The company indicates it files annual reports under cover of Form 20-F.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on March 26, 2025 regarding Evaxion Biotech A/S (EVAX).